1. Home
  2. ICCC vs AHT Comparison

ICCC vs AHT Comparison

Compare ICCC & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
    SELLHOLDBUYas of 18 hours ago
  • AHT
    SELLHOLDBUYas of 18 hours ago
  • Stock Information
  • Founded
  • ICCC 1982
  • AHT 2003
  • Country
  • ICCC United States
  • AHT United States
  • Employees
  • ICCC N/A
  • AHT N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • AHT Real Estate Investment Trusts
  • Sector
  • ICCC Health Care
  • AHT Real Estate
  • Exchange
  • ICCC Nasdaq
  • AHT Nasdaq
  • Market Cap
  • ICCC 39.2M
  • AHT 40.8M
  • IPO Year
  • ICCC 1987
  • AHT 2003
  • Fundamental
  • Price
  • ICCC $4.97
  • AHT $7.22
  • Analyst Decision
  • ICCC
  • AHT
  • Analyst Count
  • ICCC 0
  • AHT 0
  • Target Price
  • ICCC N/A
  • AHT N/A
  • AVG Volume (30 Days)
  • ICCC 11.2K
  • AHT 22.0K
  • Earning Date
  • ICCC 05-13-2025
  • AHT 05-06-2025
  • Dividend Yield
  • ICCC N/A
  • AHT N/A
  • EPS Growth
  • ICCC N/A
  • AHT N/A
  • EPS
  • ICCC N/A
  • AHT N/A
  • Revenue
  • ICCC $26,493,000.00
  • AHT $1,170,089,000.00
  • Revenue This Year
  • ICCC N/A
  • AHT N/A
  • Revenue Next Year
  • ICCC N/A
  • AHT N/A
  • P/E Ratio
  • ICCC N/A
  • AHT N/A
  • Revenue Growth
  • ICCC 51.63
  • AHT N/A
  • 52 Week Low
  • ICCC $3.34
  • AHT $5.20
  • 52 Week High
  • ICCC $5.82
  • AHT $14.90
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 48.48
  • AHT 36.95
  • Support Level
  • ICCC $4.56
  • AHT $7.16
  • Resistance Level
  • ICCC $5.05
  • AHT $7.53
  • Average True Range (ATR)
  • ICCC 0.23
  • AHT 0.33
  • MACD
  • ICCC 0.01
  • AHT -0.02
  • Stochastic Oscillator
  • ICCC 80.51
  • AHT 17.02

Stock Price Comparison Chart: ICCC vs AHT

ICCC
AHT
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250510152025303540455055606570ICCC VS AHT

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides rest estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use